tirzepatide cvot In patients with type 2 diabetes and atherosclerotic cardiovascular disease, was noninferior to dulaglutide with respect to major cardiovascular events. Full SURPASS-CVOT trial results: https://nej.md/4qd5rLx SURPASS-CVOT: Tirzepatide Significantly Reduces Major

We believe that reliable research can only be built on a foundation of impeccably sourced and verified materials

See section When should you be careful when using Wegovy Multi FixDose? for information on the increased risk of hypoglycaemia and the section What side effects can Wegovy Multi FixDose have? about the warning signs of hypoglycemia

Following guidance from your healthcare provider and slowly increasing your dose could help to reduce these side effects

You also get six automatic status emails per order, so you always know where things stand: order placed, provider review complete, pharmacy filled, on its way, out for delivery, and delivered